ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 0880 • ACR Convergence 2021

    Health Information Use by SLE Patients Pre and During COVID-19

    Francesca Cardwell1, Susan Elliott2, May Choi3, Ricky Chin3, Yvan St.Pierre4, Leigha Rowbottom5, Murray Urowitz6, Guillermo Ruiz-Irastorza7, Sasha Bernatsky8, Michelle Petri9, Susan Manzi10, Christine Peschken11, Rosalind Ramsey-Goldman12, Paul R Fortin13, Jungmin Shin14, Sang-Cheol Bae15, Jiacai Cho16, Anselm Mak17, John Hanly18, Anca Askanase19, Juanita Romero-Diaz20, Romina Nieto21, Bernardo A. Pons-Estel22, Ian N. Bruce23, Daniel Wallace24 and Ann Clarke5, 1University of Waterloo, Burlington, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 4Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 5University of Calgary, Calgary, AB, Canada, 6Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, ON, Canada, 7Hospital Universitario Cruces, University of the Basque Country, Bizkaia, Spain, 8McGill University, Montréal, QC, Canada, 9Johns Hopkins University School of Medicine, Baltimore, MD, 10Allegheny Health Network, Wexford, PA, 11University of Manitoba, Winnipeg, MB, Canada, 12Northwestern University, Chicago, IL, 13CHU de Quebec - Universite Laval, Québec City, QC, Canada, 14Hanyang University Hospital, Seoul, Republic of Korea, 15Hanyang University Medical Center, Seoul, Republic of Korea, 16National University Health System (NUHS), Singapore, Singapore, 17National University of Singapore, Singapore, Singapore, 18Dalhousie University, Halifax, NS, Canada, 19Columbia University Medical Center, New York, NY, 20Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, Federal District, Mexico, 21Hospital Provincial de Rosario, Rosario, Argentina, 22Grupo Oroo - Centro Regional de Enfermedades Autoinmunes y Reumticas (GO-CREAR), Rosario, Argentina, 23University of Manchester, Manchester, United Kingdom, 24Cedars-Sinai, Los Angeles, CA

    Background/Purpose: The spread of COVID-19 misinformation is especially serious for individuals with complex diseases like SLE; conflicting and/or unfounded information can complicate a patient’s health…
  • Abstract Number: 0886 • ACR Convergence 2021

    Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample

    Francesca Cardwell1, Susan Elliott2, Ricky Chin3, Leigha Rowbottom4, Yvan St.Pierre5, May Choi3, Murray Urowitz6, Guillermo Ruiz-Irastorza7, Sasha Bernatsky8, Michelle Petri9, Susan Manzi10, Christine Peschken11, Rosalind Ramsey-Goldman12, Paul R Fortin13, Jungmin Shin14, Sang-Cheol Bae15, Jiacai Cho16, Anselm Mak17, John Hanly18, Anca Askanase19, Juanita Romero-Diaz20, Romina Nieto21, Bernardo A. Pons-Estel22, Ian N. Bruce23, Daniel Wallace24 and Ann Clarke4, 1University of Waterloo, Burlington, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 6Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, ON, Canada, 7Hospital Universitario Cruces, University of the Basque Country, Bizkaia, Spain, 8McGill University, Montréal, QC, Canada, 9Johns Hopkins University School of Medicine, Baltimore, MD, 10Allegheny Health Network, Wexford, PA, 11University of Manitoba, Winnipeg, MB, Canada, 12Northwestern University, Chicago, IL, 13CHU de Quebec - Universite Laval, Québec City, QC, Canada, 14Hanyang University Hospital, Seoul, Republic of Korea, 15Hanyang University Medical Center, Seoul, Republic of Korea, 16National University Health System (NUHS), Singapore, Singapore, 17National University of Singapore, Singapore, Singapore, 18Dalhousie University, Halifax, NS, Canada, 19Columbia University Medical Center, New York, NY, 20Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, Federal District, Mexico, 21Hospital Provincial de Rosario, Rosario, Argentina, 22Grupo Oroo - Centro Regional de Enfermedades Autoinmunes y Reumticas (GO-CREAR), Rosario, Argentina, 23University of Manchester, Manchester, United Kingdom, 24Cedars-Sinai, Los Angeles, CA

    Background/Purpose: The spread of COVID-19 misinformation through social/news media is a health risk in SLE. We assessed the determinants of SLE patients accessing health information…
  • Abstract Number: 1158 • ACR Convergence 2021

    Resistance of Patients with Rheumatoid Arthritis to Changing Therapy: A 15-year Follow-up

    Kaleb Michaud1, Sofia Pedro2, Victoria Jasion3, Holly Budlong4, Jessica Suboticki5, Frederick Wolfe6 and Patricia Katz7, 1University of Nebraska Medical Center, Omaha, NE, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3AbbVie, Overland Park, KS, 4AbbVie, Minneapolis, MN, 5AbbVie Inc., North Chicago, IL, 6National Data Bank for Rheumatic Diseases, Wichita, KS, 7University of California San Francisco, San Francisco, CA

    Background/Purpose: Treatment options for rheumatoid arthritis (RA) have increased dramatically over the past 15 years. The objective of this study was to investigate whether willingness…
  • Abstract Number: 1287 • ACR Convergence 2021

    Association of Limited Health Literacy with Patient-Provider Communication in Systemic Lupus Erythematosus

    Ann Barr1, Catherine Howe2, Jennifer Rogers1, Jayanth Doss1, Rebecca Sadun1, Lisa Criscione-Schreiber3, Megan Clowse4, Kai Sun3 and Mithu Maheswaranathan3, 1Duke University, Durham, NC, 2Duke University Hospital, Durham, NC, 3Duke University School of Medicine, Durham, NC, 4Duke University, Chapel Hill, NC

    Background/Purpose: Low health literacy is common among US adults, including patients with SLE, and is associated with higher disease activity and worse patient-reported outcomes. The…
  • Abstract Number: 1371 • ACR Convergence 2021

    Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches

    Susan Murphy1, Yen Chen2, Mary Alore2, Sheri Hicks2 and Dinesh Khanna2, 1University of Michigan, Grosse Ile, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: People with systemic sclerosis (SSc) have a high burden of chronic symptoms that have dramatic effects on function and quality of life. Fatigue, along…
  • Abstract Number: 0031 • ACR Convergence 2021

    A New Pharmacostatistical Model to Assess MTX-adherence in RA Patients

    Marion Geoffroy1, Claire Gozalo2, Loic Pauvele2, Elise Abboud2, Zoubir Djerada3 and Jean hugues Salmon4, 1CHU Reims, France, REIMS, France, 2CHU Reims, Reims, France, 3CHU Riems, Reims, France, 4Rheumatology, CHU Maison blanche, Reims, Reims, France

    Background/Purpose: Methotrexate (MTX) is the first-line therapy for rheumatoid arthritis (RA). While therapeutic adherence is essential to the successful management of the patient, an estimated…
  • Abstract Number: 1599 • ACR Convergence 2021

    Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision Making

    Courtney Wells1, Guadalupe Torres2, William Nowell3, Shilpa Venkatachalam3, Laura Stradford4, Kelly Gavigan3, Barbara Boyd-Floering5, Maria I. Danila6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Patient Partner, Brooklyn Center, MN, 3Global Healthy Living Foundation, Upper Nyack, NY, 4Global Healthy Living Foundation, Nyack, NY, 5Whelton Virshup CreakyJoints Arthritis Clinic/ Global Healthy Living Foundation, Lake Worth, FL, 6University of Alabama at Birmingham, Birmingham, AL, 7Independent, San Diego, CA

    Background/Purpose: The purpose of this qualitative study was to understand the concerns, behaviors, and experiences of adults with autoimmune rheumatic conditions, and to evaluate the…
  • Abstract Number: 0098 • ACR Convergence 2021

    Patients with Chronic Inflammatory Rheumatic Diseases Report a Lower Frequency of Infections Than Controls and They Protect Themselves Well Against SARS-CoV-2 Transmission

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The SARS-CoV-2 pandemic has affected life in most countries around the world for more than a year now. It is not entirely clear if…
  • Abstract Number: 1608 • ACR Convergence 2021

    Sources of Information About SARS-CoV-2 Used by Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Ioana Andreica, Iulia Roman, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) may be at increased risk of Corona Virus Disease 2019 (COVID-19).1 The quality of information obtained plays…
  • Abstract Number: 0122 • ACR Convergence 2021

    Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Stephanie Catella1, Michael Gendreau2, Nicolette Vega1, Allison Kraus1, Michael Rosenbluth1, Sherry Soefje3, Shishuka Malhotra4 and Lesley Arnold5, 1Swing Therapeutics, San Francisco, CA, 2Gendreau Consulting, LLC, Poway, CA, 3Excell Research, Oceanside, CA, 4Neuro-Behavioral Clinical Research, North Canton, OH, 5University of Cincinnati, Cincinnati, OH

    Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
  • Abstract Number: 1609 • ACR Convergence 2021

    SARS-CoV-2 Vaccination Willingness and Its Predictors in Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Whether patients with chronic rheumatic diseases (CIRD) are at increased risk of developing severe COVID 19 infections is not entirely clear. However, some DMARDs…
  • Abstract Number: 0131 • ACR Convergence 2021

    Association of Numeracy with Medication Non-Adherence in Systemic Lupus Erythematosus

    Mithu Maheswaranathan1, Amanda Eudy2, Ann Barr2, Catherine Howe3, Stacy Bailey4, Susan Hastings1, Jennifer Rogers2, Jayanth Doss2, Lisa Criscione-Schreiber1, Rebecca Sadun2, Megan Clowse5 and Kai Sun1, 1Duke University School of Medicine, Durham, NC, 2Duke University, Durham, NC, 3Duke University Hospital, Durham, NC, 4Northwestern University, Evanston, IL, 5Duke University, Chapel Hill, NC

    Background/Purpose: Over 33% of U.S. adults have limited health literacy or numeracy. Limited health literacy and numeracy have been associated with higher disease activity and…
  • Abstract Number: 1612 • ACR Convergence 2021

    Factors Associated with COVID-19 Vaccine Hesitancy Among Individuals with Rheumatic Disease

    Kristin Wipfler1, Adam Cornish1, Alison Freifeld2, Patricia Katz3 and Kaleb Michaud2, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of California San Francisco, San Francisco, CA

    Background/Purpose: COVID-19 vaccination efforts are ongoing and there is a need to understand factors associated with vaccine hesitancy. Individuals with rheumatic diseases have been uniquely…
  • Abstract Number: 0233 • ACR Convergence 2021

    Feasibility and Acceptability of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change

    Katherine Carpenter1, Melissa French1, Sara Balestrieri2, Sara Johnson2, Sarah Gilman3, Cristina Drenkard4, S Sam Lim5, Maria Dall'Era6, Emily Somers7, Suzanna Zick8, Victoria Werth9, Daniel Wallace10, Melicent Miller1 and Mary Crimmings1, 1Lupus Foundation of America, Washington, DC, 2Pro-Change Behavior Systems, South Kingstown, RI, 3Wayfinder Health Strategies, Falls Church, VA, 4Emory University, Atlanta, GA, 5Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 6University of California San Francisco, Corte Madera, CA, 7University of Michigan, Ann Arbor, MI, 8Department of Family Medicine and Nutritional Sciences, Ann Arbor, MI, 9Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, 10Cedars-Sinai, Los Angeles, CA

    Background/Purpose: The Lupus Foundation of America (LFA) has completed a 5-year cooperative agreement with the CDC to develop and evaluate an online lupus self-management (SM)…
  • Abstract Number: 1613 • ACR Convergence 2021

    Pandemic and Patients: Examining Health-Related Behaviors of Patients with Systemic Sclerosis During the COVID-19 Pandemic

    Nancy Dorr1, Patricia Fennell2 and Lee Shapiro3, 1The College of Saint Rose, Albany, NY, 2Albany Health Management Associates, Inc. Steffens Scleroderma Foundation, Albany, NY, 3Albany Medical College, Stillwater, NY

    Background/Purpose: Prior to COVID-19, few studies examined how patients with a chronic illness, such as systemic sclerosis (SSc), react to a pandemic. This study examined…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology